Long-term safety and efficacy of pregabalin as treatment of painful diabetic neuropathy (DPN): Findings from open-label extension studies

被引：0
|
作者：
Freeman, Roy
D'Urso-Decruz, Edith
Murphy, T. Kevin
Emir, Birol
机构：
来源：
DIABETES | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A151 / A151
页数：1
相关论文
共 50 条
  • [31] Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability
    Montgomery, Stuart
    Emir, Birol
    Haswell, Hannah
    Prieto, Rita
    CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (10) : 1223 - 1230
  • [32] Long-term effects of troglitazone - Open-label extension studies in type 2 diabetic patients
    Fonseca, V
    Foyt, HL
    Shen, K
    Whitcomb, R
    DIABETES CARE, 2000, 23 (03) : 354 - 359
  • [33] LONG-TERM EFFICACY OF PREGABALIN TREATMENT IN PATIENTS WITH PARTIAL-ONSET EPILEPSY: POOLED ANALYSIS OF SIX LONG-TERM, OPEN-LABEL CLINICAL STUDIES
    Emir, B.
    Bazil, C.
    Uthman, B.
    Leon, T.
    EPILEPSIA, 2009, 50 : 198 - 198
  • [34] Long-Term Efficacy and Safety of Etrasimod for Ulcerative Colitis: Results From the Open-Label Extension of the OASIS Study
    Chiorean, Michael
    Vermeire, Severine
    Panes, Julian
    Peyrin-Biroulet, Laurent
    Zhang, Jinkun
    Sands, Bruce E.
    Lazin, Krisztina
    Cabell, Chris H.
    Naik, Snehal U.
    Klassen, Preston
    Sandborn, William J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S445 - S446
  • [35] Long-term Efficacy and Safety From an Open-Label Extension of Adjunctive Cenobamate in Patients With Uncontrolled Focal Seizures
    Klein, Pavel
    Aboumatar, Sami
    Brandt, Christian
    Dong, Fang
    Krauss, Gregory L.
    Mizne, Sarah
    Sanchez-Alvarez, Juan Carlos
    Steinhoff, Bernhard J.
    Villanueva, Vicente
    NEUROLOGY, 2022, 99 (10) : E989 - E998
  • [36] Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study
    Vermeire, Severine
    Chiorean, Michael
    Panes, Julian
    Peyrin-Biroulet, Laurent
    Zhang, Jinkun
    Sands, Bruce E.
    Lazin, Krisztina
    Klassen, Preston
    Naik, Snehal U.
    Cabell, Christopher H.
    Sandborn, William J.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (06): : 950 - 959
  • [37] Pegloticase Long-Term Safety: Data From the Open-Label Extension Trial.
    Becker, Michael A.
    Baraf, Herbert S. B.
    Yood, Robert A.
    Dillon, Aileen M.
    Vazquez-Mellado, Janitzia
    Ottery, Faith D.
    Khanna, Dinesh
    Sundy, John S.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S69 - S70
  • [38] 2.3 Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis (JRA): Findings from an open-label treatment extension
    N Ruperto
    DJ Lovell
    R Cuttica
    P Woo
    G Espada
    C Wouters
    ED Silverman
    Z Balogh
    M Henrickson
    J Davidson
    I Foeldvari
    L Imundo
    G Simonini
    J Oppermann
    YK Shen
    S Visvanathan
    A Fasanmade
    A Mendelsohn
    A Martini
    EH Giannini
    Pediatric Rheumatology, 6 (Suppl 1)
  • [39] Safety and Efficacy of Pregabalin Treatment and Quality of Life in Patients Treated with Pregabalin in Painful Diabetic Peripheral Neuropathy
    Radhakrishnan, Chandni
    Ut, Anjusha
    Sreejith, K.
    Manikath, Neeraj
    Cr, Rinu R.
    DIABETES, 2018, 67
  • [40] Long-Term Safety and Efficacy of Olokizumab in Patients with Rheumatoid Arthritis - Results of an Open-Label Extension Study
    Feist, Eugen
    Nasonov, Evgeny
    Luggen, Michael
    Fatenejad, Saeed
    Grishin, Sergey
    Samsonov, Mikhail
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 603 - 606
12345